Acro Biomedical (ACBM) Short-term Investments (2018 - 2023)

Acro Biomedical (ACBM) recorded quarterly Short-term Investments of $4230.0 in Q3 2023, little changed quarter-over-quarter from $4230.0 in Q2 2023.

Acro Biomedical (ACBM) Short-term Investments (2018 - 2023) Analysis & Trends

Acro Biomedical's Short-term Investments history runs 3 years deep, the most recent figure standing at $4230.0 for Q3 2023.

In Q3 2023, Short-term Investments changed N/A year-over-year to $4230.0; the TTM figure through Sep 2023 stood at $4230.0 (changed N/A YoY), while the FY2019 annual figure was $4992.0, changed N/A from the prior year.
Short-term Investments was $4230.0 for Q3 2023 at Acro Biomedical, roughly flat from $4230.0 in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $4992.0 in Q1 2019 to a low of $4230.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	EQV Ventures Acquisition	477.93 Mn	477.93 Mn	-
2	GP-Act III Acquisition	312.80 Mn	312.80 Mn	-
3	Berto Acquisition	311.56 Mn	311.56 Mn	-
4	Churchill Capital Corp IX	310.79 Mn	310.79 Mn	-
5	Centurion Acquisition	310.21 Mn	310.21 Mn	-
6	WEN Acquisition	309.15 Mn	309.15 Mn	-
7	Agriculture & Natural Solutions Acquisition	303.81 Mn	303.81 Mn	-
8	Bold Eagle Acquisition	274.64 Mn	274.64 Mn	-
9	Live Oak Acquisition Corp. V	265.88 Mn	265.88 Mn	-
10	Acro Biomedical	-	-	-

Download Data